Global Oligonucleotides Market Research Report 2024(Status and Outlook)
Report Overview:
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The Global Oligonucleotides Market Size was estimated at USD 1394.36 million in 2023 and is projected to reach USD 2483.70 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Oligonucleotides market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotides Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oligonucleotides market in any manner.
Global Oligonucleotides Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Market Segmentation (by Type)
DNA Oligos
RNA Oligos
Market Segmentation (by Application)
Pharmaceutical
Research
Diagnostic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotides Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The Global Oligonucleotides Market Size was estimated at USD 1394.36 million in 2023 and is projected to reach USD 2483.70 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Oligonucleotides market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotides Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oligonucleotides market in any manner.
Global Oligonucleotides Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Market Segmentation (by Type)
DNA Oligos
RNA Oligos
Market Segmentation (by Application)
Pharmaceutical
Research
Diagnostic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oligonucleotides Market
- Overview of the regional outlook of the Oligonucleotides Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotides Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oligonucleotides
1.2 Key Market Segments
1.2.1 Oligonucleotides Segment by Type
1.2.2 Oligonucleotides Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotides Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oligonucleotides Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDES MARKET COMPETITIVE LANDSCAPE
3.1 Global Oligonucleotides Sales by Manufacturers (2019-2024)
3.2 Global Oligonucleotides Revenue Market Share by Manufacturers (2019-2024)
3.3 Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oligonucleotides Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oligonucleotides Sales Sites, Area Served, Product Type
3.6 Oligonucleotides Market Competitive Situation and Trends
3.6.1 Oligonucleotides Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oligonucleotides Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDES INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotides Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OLIGONUCLEOTIDES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotides Sales Market Share by Type (2019-2024)
6.3 Global Oligonucleotides Market Size Market Share by Type (2019-2024)
6.4 Global Oligonucleotides Price by Type (2019-2024)
7 OLIGONUCLEOTIDES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotides Market Sales by Application (2019-2024)
7.3 Global Oligonucleotides Market Size (M USD) by Application (2019-2024)
7.4 Global Oligonucleotides Sales Growth Rate by Application (2019-2024)
8 OLIGONUCLEOTIDES MARKET SEGMENTATION BY REGION
8.1 Global Oligonucleotides Sales by Region
8.1.1 Global Oligonucleotides Sales by Region
8.1.2 Global Oligonucleotides Sales Market Share by Region
8.2 North America
8.2.1 North America Oligonucleotides Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oligonucleotides Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oligonucleotides Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oligonucleotides Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oligonucleotides Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Integrated DNA Technologies
9.1.1 Integrated DNA Technologies Oligonucleotides Basic Information
9.1.2 Integrated DNA Technologies Oligonucleotides Product Overview
9.1.3 Integrated DNA Technologies Oligonucleotides Product Market Performance
9.1.4 Integrated DNA Technologies Business Overview
9.1.5 Integrated DNA Technologies Oligonucleotides SWOT Analysis
9.1.6 Integrated DNA Technologies Recent Developments
9.2 Agilent
9.2.1 Agilent Oligonucleotides Basic Information
9.2.2 Agilent Oligonucleotides Product Overview
9.2.3 Agilent Oligonucleotides Product Market Performance
9.2.4 Agilent Business Overview
9.2.5 Agilent Oligonucleotides SWOT Analysis
9.2.6 Agilent Recent Developments
9.3 Sigma-aldrich
9.3.1 Sigma-aldrich Oligonucleotides Basic Information
9.3.2 Sigma-aldrich Oligonucleotides Product Overview
9.3.3 Sigma-aldrich Oligonucleotides Product Market Performance
9.3.4 Sigma-aldrich Oligonucleotides SWOT Analysis
9.3.5 Sigma-aldrich Business Overview
9.3.6 Sigma-aldrich Recent Developments
9.4 Eurofins Genomics
9.4.1 Eurofins Genomics Oligonucleotides Basic Information
9.4.2 Eurofins Genomics Oligonucleotides Product Overview
9.4.3 Eurofins Genomics Oligonucleotides Product Market Performance
9.4.4 Eurofins Genomics Business Overview
9.4.5 Eurofins Genomics Recent Developments
9.5 L.G.C Biosearch Technologies
9.5.1 L.G.C Biosearch Technologies Oligonucleotides Basic Information
9.5.2 L.G.C Biosearch Technologies Oligonucleotides Product Overview
9.5.3 L.G.C Biosearch Technologies Oligonucleotides Product Market Performance
9.5.4 L.G.C Biosearch Technologies Business Overview
9.5.5 L.G.C Biosearch Technologies Recent Developments
9.6 Eurogentec S.A
9.6.1 Eurogentec S.A Oligonucleotides Basic Information
9.6.2 Eurogentec S.A Oligonucleotides Product Overview
9.6.3 Eurogentec S.A Oligonucleotides Product Market Performance
9.6.4 Eurogentec S.A Business Overview
9.6.5 Eurogentec S.A Recent Developments
9.7 Nitto Denko Avecia Inc
9.7.1 Nitto Denko Avecia Inc Oligonucleotides Basic Information
9.7.2 Nitto Denko Avecia Inc Oligonucleotides Product Overview
9.7.3 Nitto Denko Avecia Inc Oligonucleotides Product Market Performance
9.7.4 Nitto Denko Avecia Inc Business Overview
9.7.5 Nitto Denko Avecia Inc Recent Developments
9.8 GenScript
9.8.1 GenScript Oligonucleotides Basic Information
9.8.2 GenScript Oligonucleotides Product Overview
9.8.3 GenScript Oligonucleotides Product Market Performance
9.8.4 GenScript Business Overview
9.8.5 GenScript Recent Developments
9.9 BBI Life Sciences
9.9.1 BBI Life Sciences Oligonucleotides Basic Information
9.9.2 BBI Life Sciences Oligonucleotides Product Overview
9.9.3 BBI Life Sciences Oligonucleotides Product Market Performance
9.9.4 BBI Life Sciences Business Overview
9.9.5 BBI Life Sciences Recent Developments
9.10 GeneDesign
9.10.1 GeneDesign Oligonucleotides Basic Information
9.10.2 GeneDesign Oligonucleotides Product Overview
9.10.3 GeneDesign Oligonucleotides Product Market Performance
9.10.4 GeneDesign Business Overview
9.10.5 GeneDesign Recent Developments
9.11 TriLink BioTechnologies
9.11.1 TriLink BioTechnologies Oligonucleotides Basic Information
9.11.2 TriLink BioTechnologies Oligonucleotides Product Overview
9.11.3 TriLink BioTechnologies Oligonucleotides Product Market Performance
9.11.4 TriLink BioTechnologies Business Overview
9.11.5 TriLink BioTechnologies Recent Developments
9.12 SGS DNA
9.12.1 SGS DNA Oligonucleotides Basic Information
9.12.2 SGS DNA Oligonucleotides Product Overview
9.12.3 SGS DNA Oligonucleotides Product Market Performance
9.12.4 SGS DNA Business Overview
9.12.5 SGS DNA Recent Developments
9.13 LC Sciences
9.13.1 LC Sciences Oligonucleotides Basic Information
9.13.2 LC Sciences Oligonucleotides Product Overview
9.13.3 LC Sciences Oligonucleotides Product Market Performance
9.13.4 LC Sciences Business Overview
9.13.5 LC Sciences Recent Developments
9.14 Twist Bioscience
9.14.1 Twist Bioscience Oligonucleotides Basic Information
9.14.2 Twist Bioscience Oligonucleotides Product Overview
9.14.3 Twist Bioscience Oligonucleotides Product Market Performance
9.14.4 Twist Bioscience Business Overview
9.14.5 Twist Bioscience Recent Developments
9.15 Creative Biogene
9.15.1 Creative Biogene Oligonucleotides Basic Information
9.15.2 Creative Biogene Oligonucleotides Product Overview
9.15.3 Creative Biogene Oligonucleotides Product Market Performance
9.15.4 Creative Biogene Business Overview
9.15.5 Creative Biogene Recent Developments
9.16 General Biosystems
9.16.1 General Biosystems Oligonucleotides Basic Information
9.16.2 General Biosystems Oligonucleotides Product Overview
9.16.3 General Biosystems Oligonucleotides Product Market Performance
9.16.4 General Biosystems Business Overview
9.16.5 General Biosystems Recent Developments
10 OLIGONUCLEOTIDES MARKET FORECAST BY REGION
10.1 Global Oligonucleotides Market Size Forecast
10.2 Global Oligonucleotides Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oligonucleotides Market Size Forecast by Country
10.2.3 Asia Pacific Oligonucleotides Market Size Forecast by Region
10.2.4 South America Oligonucleotides Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oligonucleotides by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oligonucleotides Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oligonucleotides by Type (2025-2030)
11.1.2 Global Oligonucleotides Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oligonucleotides by Type (2025-2030)
11.2 Global Oligonucleotides Market Forecast by Application (2025-2030)
11.2.1 Global Oligonucleotides Sales (Kilotons) Forecast by Application
11.2.2 Global Oligonucleotides Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oligonucleotides
1.2 Key Market Segments
1.2.1 Oligonucleotides Segment by Type
1.2.2 Oligonucleotides Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotides Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oligonucleotides Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDES MARKET COMPETITIVE LANDSCAPE
3.1 Global Oligonucleotides Sales by Manufacturers (2019-2024)
3.2 Global Oligonucleotides Revenue Market Share by Manufacturers (2019-2024)
3.3 Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oligonucleotides Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oligonucleotides Sales Sites, Area Served, Product Type
3.6 Oligonucleotides Market Competitive Situation and Trends
3.6.1 Oligonucleotides Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oligonucleotides Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDES INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotides Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OLIGONUCLEOTIDES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotides Sales Market Share by Type (2019-2024)
6.3 Global Oligonucleotides Market Size Market Share by Type (2019-2024)
6.4 Global Oligonucleotides Price by Type (2019-2024)
7 OLIGONUCLEOTIDES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotides Market Sales by Application (2019-2024)
7.3 Global Oligonucleotides Market Size (M USD) by Application (2019-2024)
7.4 Global Oligonucleotides Sales Growth Rate by Application (2019-2024)
8 OLIGONUCLEOTIDES MARKET SEGMENTATION BY REGION
8.1 Global Oligonucleotides Sales by Region
8.1.1 Global Oligonucleotides Sales by Region
8.1.2 Global Oligonucleotides Sales Market Share by Region
8.2 North America
8.2.1 North America Oligonucleotides Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oligonucleotides Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oligonucleotides Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oligonucleotides Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oligonucleotides Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Integrated DNA Technologies
9.1.1 Integrated DNA Technologies Oligonucleotides Basic Information
9.1.2 Integrated DNA Technologies Oligonucleotides Product Overview
9.1.3 Integrated DNA Technologies Oligonucleotides Product Market Performance
9.1.4 Integrated DNA Technologies Business Overview
9.1.5 Integrated DNA Technologies Oligonucleotides SWOT Analysis
9.1.6 Integrated DNA Technologies Recent Developments
9.2 Agilent
9.2.1 Agilent Oligonucleotides Basic Information
9.2.2 Agilent Oligonucleotides Product Overview
9.2.3 Agilent Oligonucleotides Product Market Performance
9.2.4 Agilent Business Overview
9.2.5 Agilent Oligonucleotides SWOT Analysis
9.2.6 Agilent Recent Developments
9.3 Sigma-aldrich
9.3.1 Sigma-aldrich Oligonucleotides Basic Information
9.3.2 Sigma-aldrich Oligonucleotides Product Overview
9.3.3 Sigma-aldrich Oligonucleotides Product Market Performance
9.3.4 Sigma-aldrich Oligonucleotides SWOT Analysis
9.3.5 Sigma-aldrich Business Overview
9.3.6 Sigma-aldrich Recent Developments
9.4 Eurofins Genomics
9.4.1 Eurofins Genomics Oligonucleotides Basic Information
9.4.2 Eurofins Genomics Oligonucleotides Product Overview
9.4.3 Eurofins Genomics Oligonucleotides Product Market Performance
9.4.4 Eurofins Genomics Business Overview
9.4.5 Eurofins Genomics Recent Developments
9.5 L.G.C Biosearch Technologies
9.5.1 L.G.C Biosearch Technologies Oligonucleotides Basic Information
9.5.2 L.G.C Biosearch Technologies Oligonucleotides Product Overview
9.5.3 L.G.C Biosearch Technologies Oligonucleotides Product Market Performance
9.5.4 L.G.C Biosearch Technologies Business Overview
9.5.5 L.G.C Biosearch Technologies Recent Developments
9.6 Eurogentec S.A
9.6.1 Eurogentec S.A Oligonucleotides Basic Information
9.6.2 Eurogentec S.A Oligonucleotides Product Overview
9.6.3 Eurogentec S.A Oligonucleotides Product Market Performance
9.6.4 Eurogentec S.A Business Overview
9.6.5 Eurogentec S.A Recent Developments
9.7 Nitto Denko Avecia Inc
9.7.1 Nitto Denko Avecia Inc Oligonucleotides Basic Information
9.7.2 Nitto Denko Avecia Inc Oligonucleotides Product Overview
9.7.3 Nitto Denko Avecia Inc Oligonucleotides Product Market Performance
9.7.4 Nitto Denko Avecia Inc Business Overview
9.7.5 Nitto Denko Avecia Inc Recent Developments
9.8 GenScript
9.8.1 GenScript Oligonucleotides Basic Information
9.8.2 GenScript Oligonucleotides Product Overview
9.8.3 GenScript Oligonucleotides Product Market Performance
9.8.4 GenScript Business Overview
9.8.5 GenScript Recent Developments
9.9 BBI Life Sciences
9.9.1 BBI Life Sciences Oligonucleotides Basic Information
9.9.2 BBI Life Sciences Oligonucleotides Product Overview
9.9.3 BBI Life Sciences Oligonucleotides Product Market Performance
9.9.4 BBI Life Sciences Business Overview
9.9.5 BBI Life Sciences Recent Developments
9.10 GeneDesign
9.10.1 GeneDesign Oligonucleotides Basic Information
9.10.2 GeneDesign Oligonucleotides Product Overview
9.10.3 GeneDesign Oligonucleotides Product Market Performance
9.10.4 GeneDesign Business Overview
9.10.5 GeneDesign Recent Developments
9.11 TriLink BioTechnologies
9.11.1 TriLink BioTechnologies Oligonucleotides Basic Information
9.11.2 TriLink BioTechnologies Oligonucleotides Product Overview
9.11.3 TriLink BioTechnologies Oligonucleotides Product Market Performance
9.11.4 TriLink BioTechnologies Business Overview
9.11.5 TriLink BioTechnologies Recent Developments
9.12 SGS DNA
9.12.1 SGS DNA Oligonucleotides Basic Information
9.12.2 SGS DNA Oligonucleotides Product Overview
9.12.3 SGS DNA Oligonucleotides Product Market Performance
9.12.4 SGS DNA Business Overview
9.12.5 SGS DNA Recent Developments
9.13 LC Sciences
9.13.1 LC Sciences Oligonucleotides Basic Information
9.13.2 LC Sciences Oligonucleotides Product Overview
9.13.3 LC Sciences Oligonucleotides Product Market Performance
9.13.4 LC Sciences Business Overview
9.13.5 LC Sciences Recent Developments
9.14 Twist Bioscience
9.14.1 Twist Bioscience Oligonucleotides Basic Information
9.14.2 Twist Bioscience Oligonucleotides Product Overview
9.14.3 Twist Bioscience Oligonucleotides Product Market Performance
9.14.4 Twist Bioscience Business Overview
9.14.5 Twist Bioscience Recent Developments
9.15 Creative Biogene
9.15.1 Creative Biogene Oligonucleotides Basic Information
9.15.2 Creative Biogene Oligonucleotides Product Overview
9.15.3 Creative Biogene Oligonucleotides Product Market Performance
9.15.4 Creative Biogene Business Overview
9.15.5 Creative Biogene Recent Developments
9.16 General Biosystems
9.16.1 General Biosystems Oligonucleotides Basic Information
9.16.2 General Biosystems Oligonucleotides Product Overview
9.16.3 General Biosystems Oligonucleotides Product Market Performance
9.16.4 General Biosystems Business Overview
9.16.5 General Biosystems Recent Developments
10 OLIGONUCLEOTIDES MARKET FORECAST BY REGION
10.1 Global Oligonucleotides Market Size Forecast
10.2 Global Oligonucleotides Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oligonucleotides Market Size Forecast by Country
10.2.3 Asia Pacific Oligonucleotides Market Size Forecast by Region
10.2.4 South America Oligonucleotides Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oligonucleotides by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oligonucleotides Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oligonucleotides by Type (2025-2030)
11.1.2 Global Oligonucleotides Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oligonucleotides by Type (2025-2030)
11.2 Global Oligonucleotides Market Forecast by Application (2025-2030)
11.2.1 Global Oligonucleotides Sales (Kilotons) Forecast by Application
11.2.2 Global Oligonucleotides Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oligonucleotides Market Size Comparison by Region (M USD)
Table 5. Global Oligonucleotides Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oligonucleotides Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oligonucleotides Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oligonucleotides Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2022)
Table 10. Global Market Oligonucleotides Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oligonucleotides Sales Sites and Area Served
Table 12. Manufacturers Oligonucleotides Product Type
Table 13. Global Oligonucleotides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oligonucleotides
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotides Market Challenges
Table 22. Global Oligonucleotides Sales by Type (Kilotons)
Table 23. Global Oligonucleotides Market Size by Type (M USD)
Table 24. Global Oligonucleotides Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oligonucleotides Sales Market Share by Type (2019-2024)
Table 26. Global Oligonucleotides Market Size (M USD) by Type (2019-2024)
Table 27. Global Oligonucleotides Market Size Share by Type (2019-2024)
Table 28. Global Oligonucleotides Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oligonucleotides Sales (Kilotons) by Application
Table 30. Global Oligonucleotides Market Size by Application
Table 31. Global Oligonucleotides Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oligonucleotides Sales Market Share by Application (2019-2024)
Table 33. Global Oligonucleotides Sales by Application (2019-2024) & (M USD)
Table 34. Global Oligonucleotides Market Share by Application (2019-2024)
Table 35. Global Oligonucleotides Sales Growth Rate by Application (2019-2024)
Table 36. Global Oligonucleotides Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oligonucleotides Sales Market Share by Region (2019-2024)
Table 38. North America Oligonucleotides Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oligonucleotides Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oligonucleotides Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oligonucleotides Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oligonucleotides Sales by Region (2019-2024) & (Kilotons)
Table 43. Integrated DNA Technologies Oligonucleotides Basic Information
Table 44. Integrated DNA Technologies Oligonucleotides Product Overview
Table 45. Integrated DNA Technologies Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Integrated DNA Technologies Business Overview
Table 47. Integrated DNA Technologies Oligonucleotides SWOT Analysis
Table 48. Integrated DNA Technologies Recent Developments
Table 49. Agilent Oligonucleotides Basic Information
Table 50. Agilent Oligonucleotides Product Overview
Table 51. Agilent Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Agilent Business Overview
Table 53. Agilent Oligonucleotides SWOT Analysis
Table 54. Agilent Recent Developments
Table 55. Sigma-aldrich Oligonucleotides Basic Information
Table 56. Sigma-aldrich Oligonucleotides Product Overview
Table 57. Sigma-aldrich Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sigma-aldrich Oligonucleotides SWOT Analysis
Table 59. Sigma-aldrich Business Overview
Table 60. Sigma-aldrich Recent Developments
Table 61. Eurofins Genomics Oligonucleotides Basic Information
Table 62. Eurofins Genomics Oligonucleotides Product Overview
Table 63. Eurofins Genomics Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Eurofins Genomics Business Overview
Table 65. Eurofins Genomics Recent Developments
Table 66. L.G.C Biosearch Technologies Oligonucleotides Basic Information
Table 67. L.G.C Biosearch Technologies Oligonucleotides Product Overview
Table 68. L.G.C Biosearch Technologies Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. L.G.C Biosearch Technologies Business Overview
Table 70. L.G.C Biosearch Technologies Recent Developments
Table 71. Eurogentec S.A Oligonucleotides Basic Information
Table 72. Eurogentec S.A Oligonucleotides Product Overview
Table 73. Eurogentec S.A Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Eurogentec S.A Business Overview
Table 75. Eurogentec S.A Recent Developments
Table 76. Nitto Denko Avecia Inc Oligonucleotides Basic Information
Table 77. Nitto Denko Avecia Inc Oligonucleotides Product Overview
Table 78. Nitto Denko Avecia Inc Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Nitto Denko Avecia Inc Business Overview
Table 80. Nitto Denko Avecia Inc Recent Developments
Table 81. GenScript Oligonucleotides Basic Information
Table 82. GenScript Oligonucleotides Product Overview
Table 83. GenScript Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GenScript Business Overview
Table 85. GenScript Recent Developments
Table 86. BBI Life Sciences Oligonucleotides Basic Information
Table 87. BBI Life Sciences Oligonucleotides Product Overview
Table 88. BBI Life Sciences Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BBI Life Sciences Business Overview
Table 90. BBI Life Sciences Recent Developments
Table 91. GeneDesign Oligonucleotides Basic Information
Table 92. GeneDesign Oligonucleotides Product Overview
Table 93. GeneDesign Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. GeneDesign Business Overview
Table 95. GeneDesign Recent Developments
Table 96. TriLink BioTechnologies Oligonucleotides Basic Information
Table 97. TriLink BioTechnologies Oligonucleotides Product Overview
Table 98. TriLink BioTechnologies Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. TriLink BioTechnologies Business Overview
Table 100. TriLink BioTechnologies Recent Developments
Table 101. SGS DNA Oligonucleotides Basic Information
Table 102. SGS DNA Oligonucleotides Product Overview
Table 103. SGS DNA Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. SGS DNA Business Overview
Table 105. SGS DNA Recent Developments
Table 106. LC Sciences Oligonucleotides Basic Information
Table 107. LC Sciences Oligonucleotides Product Overview
Table 108. LC Sciences Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. LC Sciences Business Overview
Table 110. LC Sciences Recent Developments
Table 111. Twist Bioscience Oligonucleotides Basic Information
Table 112. Twist Bioscience Oligonucleotides Product Overview
Table 113. Twist Bioscience Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Twist Bioscience Business Overview
Table 115. Twist Bioscience Recent Developments
Table 116. Creative Biogene Oligonucleotides Basic Information
Table 117. Creative Biogene Oligonucleotides Product Overview
Table 118. Creative Biogene Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Creative Biogene Business Overview
Table 120. Creative Biogene Recent Developments
Table 121. General Biosystems Oligonucleotides Basic Information
Table 122. General Biosystems Oligonucleotides Product Overview
Table 123. General Biosystems Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. General Biosystems Business Overview
Table 125. General Biosystems Recent Developments
Table 126. Global Oligonucleotides Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Oligonucleotides Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Oligonucleotides Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Oligonucleotides Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Oligonucleotides Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Oligonucleotides Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Oligonucleotides Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Oligonucleotides Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Oligonucleotides Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Oligonucleotides Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Oligonucleotides Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Oligonucleotides Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Oligonucleotides Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oligonucleotides Market Size Comparison by Region (M USD)
Table 5. Global Oligonucleotides Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oligonucleotides Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oligonucleotides Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oligonucleotides Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2022)
Table 10. Global Market Oligonucleotides Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oligonucleotides Sales Sites and Area Served
Table 12. Manufacturers Oligonucleotides Product Type
Table 13. Global Oligonucleotides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oligonucleotides
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotides Market Challenges
Table 22. Global Oligonucleotides Sales by Type (Kilotons)
Table 23. Global Oligonucleotides Market Size by Type (M USD)
Table 24. Global Oligonucleotides Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oligonucleotides Sales Market Share by Type (2019-2024)
Table 26. Global Oligonucleotides Market Size (M USD) by Type (2019-2024)
Table 27. Global Oligonucleotides Market Size Share by Type (2019-2024)
Table 28. Global Oligonucleotides Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oligonucleotides Sales (Kilotons) by Application
Table 30. Global Oligonucleotides Market Size by Application
Table 31. Global Oligonucleotides Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oligonucleotides Sales Market Share by Application (2019-2024)
Table 33. Global Oligonucleotides Sales by Application (2019-2024) & (M USD)
Table 34. Global Oligonucleotides Market Share by Application (2019-2024)
Table 35. Global Oligonucleotides Sales Growth Rate by Application (2019-2024)
Table 36. Global Oligonucleotides Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oligonucleotides Sales Market Share by Region (2019-2024)
Table 38. North America Oligonucleotides Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oligonucleotides Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oligonucleotides Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oligonucleotides Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oligonucleotides Sales by Region (2019-2024) & (Kilotons)
Table 43. Integrated DNA Technologies Oligonucleotides Basic Information
Table 44. Integrated DNA Technologies Oligonucleotides Product Overview
Table 45. Integrated DNA Technologies Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Integrated DNA Technologies Business Overview
Table 47. Integrated DNA Technologies Oligonucleotides SWOT Analysis
Table 48. Integrated DNA Technologies Recent Developments
Table 49. Agilent Oligonucleotides Basic Information
Table 50. Agilent Oligonucleotides Product Overview
Table 51. Agilent Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Agilent Business Overview
Table 53. Agilent Oligonucleotides SWOT Analysis
Table 54. Agilent Recent Developments
Table 55. Sigma-aldrich Oligonucleotides Basic Information
Table 56. Sigma-aldrich Oligonucleotides Product Overview
Table 57. Sigma-aldrich Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sigma-aldrich Oligonucleotides SWOT Analysis
Table 59. Sigma-aldrich Business Overview
Table 60. Sigma-aldrich Recent Developments
Table 61. Eurofins Genomics Oligonucleotides Basic Information
Table 62. Eurofins Genomics Oligonucleotides Product Overview
Table 63. Eurofins Genomics Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Eurofins Genomics Business Overview
Table 65. Eurofins Genomics Recent Developments
Table 66. L.G.C Biosearch Technologies Oligonucleotides Basic Information
Table 67. L.G.C Biosearch Technologies Oligonucleotides Product Overview
Table 68. L.G.C Biosearch Technologies Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. L.G.C Biosearch Technologies Business Overview
Table 70. L.G.C Biosearch Technologies Recent Developments
Table 71. Eurogentec S.A Oligonucleotides Basic Information
Table 72. Eurogentec S.A Oligonucleotides Product Overview
Table 73. Eurogentec S.A Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Eurogentec S.A Business Overview
Table 75. Eurogentec S.A Recent Developments
Table 76. Nitto Denko Avecia Inc Oligonucleotides Basic Information
Table 77. Nitto Denko Avecia Inc Oligonucleotides Product Overview
Table 78. Nitto Denko Avecia Inc Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Nitto Denko Avecia Inc Business Overview
Table 80. Nitto Denko Avecia Inc Recent Developments
Table 81. GenScript Oligonucleotides Basic Information
Table 82. GenScript Oligonucleotides Product Overview
Table 83. GenScript Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GenScript Business Overview
Table 85. GenScript Recent Developments
Table 86. BBI Life Sciences Oligonucleotides Basic Information
Table 87. BBI Life Sciences Oligonucleotides Product Overview
Table 88. BBI Life Sciences Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. BBI Life Sciences Business Overview
Table 90. BBI Life Sciences Recent Developments
Table 91. GeneDesign Oligonucleotides Basic Information
Table 92. GeneDesign Oligonucleotides Product Overview
Table 93. GeneDesign Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. GeneDesign Business Overview
Table 95. GeneDesign Recent Developments
Table 96. TriLink BioTechnologies Oligonucleotides Basic Information
Table 97. TriLink BioTechnologies Oligonucleotides Product Overview
Table 98. TriLink BioTechnologies Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. TriLink BioTechnologies Business Overview
Table 100. TriLink BioTechnologies Recent Developments
Table 101. SGS DNA Oligonucleotides Basic Information
Table 102. SGS DNA Oligonucleotides Product Overview
Table 103. SGS DNA Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. SGS DNA Business Overview
Table 105. SGS DNA Recent Developments
Table 106. LC Sciences Oligonucleotides Basic Information
Table 107. LC Sciences Oligonucleotides Product Overview
Table 108. LC Sciences Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. LC Sciences Business Overview
Table 110. LC Sciences Recent Developments
Table 111. Twist Bioscience Oligonucleotides Basic Information
Table 112. Twist Bioscience Oligonucleotides Product Overview
Table 113. Twist Bioscience Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Twist Bioscience Business Overview
Table 115. Twist Bioscience Recent Developments
Table 116. Creative Biogene Oligonucleotides Basic Information
Table 117. Creative Biogene Oligonucleotides Product Overview
Table 118. Creative Biogene Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Creative Biogene Business Overview
Table 120. Creative Biogene Recent Developments
Table 121. General Biosystems Oligonucleotides Basic Information
Table 122. General Biosystems Oligonucleotides Product Overview
Table 123. General Biosystems Oligonucleotides Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. General Biosystems Business Overview
Table 125. General Biosystems Recent Developments
Table 126. Global Oligonucleotides Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Oligonucleotides Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Oligonucleotides Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Oligonucleotides Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Oligonucleotides Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Oligonucleotides Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Oligonucleotides Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Oligonucleotides Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Oligonucleotides Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Oligonucleotides Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Oligonucleotides Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Oligonucleotides Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Oligonucleotides Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Oligonucleotides Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oligonucleotides
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotides Market Size (M USD), 2019-2030
Figure 5. Global Oligonucleotides Market Size (M USD) (2019-2030)
Figure 6. Global Oligonucleotides Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotides Market Size by Country (M USD)
Figure 11. Oligonucleotides Sales Share by Manufacturers in 2023
Figure 12. Global Oligonucleotides Revenue Share by Manufacturers in 2023
Figure 13. Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oligonucleotides Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oligonucleotides Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oligonucleotides Market Share by Type
Figure 18. Sales Market Share of Oligonucleotides by Type (2019-2024)
Figure 19. Sales Market Share of Oligonucleotides by Type in 2023
Figure 20. Market Size Share of Oligonucleotides by Type (2019-2024)
Figure 21. Market Size Market Share of Oligonucleotides by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oligonucleotides Market Share by Application
Figure 24. Global Oligonucleotides Sales Market Share by Application (2019-2024)
Figure 25. Global Oligonucleotides Sales Market Share by Application in 2023
Figure 26. Global Oligonucleotides Market Share by Application (2019-2024)
Figure 27. Global Oligonucleotides Market Share by Application in 2023
Figure 28. Global Oligonucleotides Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oligonucleotides Sales Market Share by Region (2019-2024)
Figure 30. North America Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oligonucleotides Sales Market Share by Country in 2023
Figure 32. U.S. Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oligonucleotides Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oligonucleotides Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oligonucleotides Sales Market Share by Country in 2023
Figure 37. Germany Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oligonucleotides Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oligonucleotides Sales Market Share by Region in 2023
Figure 44. China Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oligonucleotides Sales and Growth Rate (Kilotons)
Figure 50. South America Oligonucleotides Sales Market Share by Country in 2023
Figure 51. Brazil Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oligonucleotides Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oligonucleotides Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oligonucleotides Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oligonucleotides Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oligonucleotides Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oligonucleotides Market Share Forecast by Type (2025-2030)
Figure 65. Global Oligonucleotides Sales Forecast by Application (2025-2030)
Figure 66. Global Oligonucleotides Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Oligonucleotides
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotides Market Size (M USD), 2019-2030
Figure 5. Global Oligonucleotides Market Size (M USD) (2019-2030)
Figure 6. Global Oligonucleotides Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotides Market Size by Country (M USD)
Figure 11. Oligonucleotides Sales Share by Manufacturers in 2023
Figure 12. Global Oligonucleotides Revenue Share by Manufacturers in 2023
Figure 13. Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oligonucleotides Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oligonucleotides Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oligonucleotides Market Share by Type
Figure 18. Sales Market Share of Oligonucleotides by Type (2019-2024)
Figure 19. Sales Market Share of Oligonucleotides by Type in 2023
Figure 20. Market Size Share of Oligonucleotides by Type (2019-2024)
Figure 21. Market Size Market Share of Oligonucleotides by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oligonucleotides Market Share by Application
Figure 24. Global Oligonucleotides Sales Market Share by Application (2019-2024)
Figure 25. Global Oligonucleotides Sales Market Share by Application in 2023
Figure 26. Global Oligonucleotides Market Share by Application (2019-2024)
Figure 27. Global Oligonucleotides Market Share by Application in 2023
Figure 28. Global Oligonucleotides Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oligonucleotides Sales Market Share by Region (2019-2024)
Figure 30. North America Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oligonucleotides Sales Market Share by Country in 2023
Figure 32. U.S. Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oligonucleotides Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oligonucleotides Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oligonucleotides Sales Market Share by Country in 2023
Figure 37. Germany Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oligonucleotides Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oligonucleotides Sales Market Share by Region in 2023
Figure 44. China Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oligonucleotides Sales and Growth Rate (Kilotons)
Figure 50. South America Oligonucleotides Sales Market Share by Country in 2023
Figure 51. Brazil Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oligonucleotides Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oligonucleotides Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oligonucleotides Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oligonucleotides Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oligonucleotides Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oligonucleotides Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oligonucleotides Market Share Forecast by Type (2025-2030)
Figure 65. Global Oligonucleotides Sales Forecast by Application (2025-2030)
Figure 66. Global Oligonucleotides Market Share Forecast by Application (2025-2030)
